Skip to content

Drug interactions

Bosentan + Cobimetinib

Severity: Major

Bosentan and Cobimetinib: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Bosentan, a moderate CYP3A4 inducer, may markedly reduce cobimetinib exposure and thus its anticancer activity.

What this interaction means in plain words

Bosentan and Cobimetinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Bosentan belongs to Miscellaneous; Cobimetinib belongs to Oncology.

Evidence level: Moderate

Why it happens

CYP3A4 induction by bosentan increases cobimetinib clearance.

What to do

Avoid coadministration; use an alternative to bosentan or consider a different therapy, and monitor tumor response if unavoidable.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Bosentan and Cobimetinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Bosentan with Cobimetinib?

MediHelp rates the interaction as major. Bosentan and Cobimetinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Bosentan, a moderate CYP3A4 inducer, may markedly reduce cobimetinib exposure and thus its anticancer activity.

How serious is the interaction between Bosentan and Cobimetinib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid coadministration; use an alternative to bosentan or consider a different therapy, and monitor tumor response if unavoidable.

What other medicines interact with Bosentan?

MediHelp also lists interactions of Bosentan with, for example, Cyclosporin, Cyclosporine, Glyburide. The full list is on the Bosentan page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in